Results 81 to 90 of about 1,935,200 (187)

Very late stent thrombosis of Sirolimus-eluting stent 59 months after implantation: A first report from the Middle-East and review of literature

Heart Views, 2011
Very late stent thrombosis occurs more frequently with drug-eluting stents and tends to occur despite dual antiplatelet therapy or after long periods of clopidogrel discontinuation.
Prashanth Panduranga, Mohammed Al-Mukhaini   +1 more
doaj   +1 more source

Elevated Lipoprotein(a) Predicts Recurrent Myocardial Infarction in Diabetic Patients Following Acute Coronary Syndromes

Clinical Cardiology, Volume 49, Issue 11, November 2026.
Elevated lipoprotein(a) levels are associated with an increased risk of recurrent myocardial infarction in diabetic patients following acute coronary syndromes or PCI, but not with repeat revascularization. These findings highlight Lp(a) as a key contributor to residual cardiovascular risk and a potential tool for post‐ACS risk stratification. ABSTRACT
Ermilo Echeverria‐Ortegon, Mario César Torres‐Chávez, Alfredo Pérez‐Tagle Tejeda, Paulina Caballero‐Osorno, Juan Pastor‐Cervantes, Hugo Laviada‐Molina   +5 more
wiley   +1 more source

A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease

Biologics: Targets & Therapy, 2013
Johan Bennett, Christophe DuboisDepartment of Cardiovascular Diseases, University Hospitals Leuven, Leuven, BelgiumAbstract: The development of coronary stents represents a major step forward in the treatment of obstructive coronary artery disease since ...
Bennett J, Dubois C
doaj  

Research progress of drug eluting balloon in arterial circulatory system

Frontiers in Cardiovascular Medicine
The arterial circulatory system diseases are common in clinical practice, and their treatment options have been of great interest due to their high morbidity and mortality.
Keji Lu, Keji Lu, Xianglin Ye, Xianglin Ye, Yaoxuan Chen, Peng Wang, Meiting Gong, Bing Xuan, Zhaobing Tang, Meiling Li, Jun Hou, Ke Peng, Haifeng Pei, Haifeng Pei   +13 more
doaj   +1 more source

Welcoming Novelty in the Treatment of Coronary Artery Disease: FDA Approves the Use of Drug‐Coated Balloon for Angioplasty

Clinical Cardiology, Volume 49, Issue 11, November 2026.
The US FDA has approved the use of drug‐coated balloons (DCBs) for treating in‐stent restenosis, a major challenge in coronary artery disease management. The AGENT IDE Trial, a multicenter randomized study, evaluated the efficacy of the paclitaxel‐coated balloon catheter, demonstrating reduced rates of target lesion failure, myocardial infarction, and ...
Abdul Haseeb Hasan, Muhammad Ali Abid, Abubakar Nazir   +2 more
wiley   +1 more source

Drug-eluting coronary stents – focus on improved patient outcomes

, 2011
Zehra Jaffery, Amit Prasad, John H Lee, Christopher J WhiteDepartment of Cardiovascular Diseases, The John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, LA, USAAbstract: The development of stent has been a major advance in
White CJ, Prasad A, Jaffery Z, Lee JH
core  

Future Directions of Drug‐Eluting Stents

, 2009
Coronary artery stents have changed the face of interventional cardiology since their introduction in 1986. The commercial release of drug-eluting stents in 2002 promised to abolish in-stent restenosis as the predominant clinical limitation following ...
YOSHINOBU ONUMA, Kukreja, N, Serruys, PWJC (Patrick), NEVILLE KUKREJA, PATRICK W. SERRUYS, Onuma, Yoshinobu   +5 more
core   +1 more source

Neointimal Hyperplasia and Restenosis: Epidemiology, Pathophysiology, Animal Models, Clinical Features, Diagnosis, and Management

MedComm, Volume 7, Issue 11, November 2026.
The overall graphical diagram to summarize the pathological characteristics, pathogenesis, clinical manifestation, preclinical animal models, diagnostic methods, and intervention strategies for neointimal hyperplasia. Neointimal hyperplasia results from excessive proliferation and intimal migration of vascular smooth muscle cells (VSMCs) in the ...
Kaixu Wang, Daiyu Zhang, Yu Hu, Yixin Zhao, Xinling Wang, Long Jiang, Meixiu Jiang   +6 more
wiley   +1 more source

Consensus Conference italiana sui “drug-eluting stents” [Italian Consensus Conference on drug-eluting stents]

, 2004
[Italian Consensus Conference on drug-eluting stents]
BERARDI F., KLUGMANN S., PETRONIO, ANNA, DANZI G. B., PALOSCIA L., SCHERILLO M., BARTORELLI A., GALASSI A. R., VASSANELLI C., DELLA GRAZIA E., BOLOGNESE L., MONTINARO A., MARZILLI, MARIO, INDOLFI C.   +13 more
core  

A drug-free cardiovascular stent functionalized with tailored collagen supports in-situ healing of vascular tissues

Nature Communications
Drug-eluting stent implantation suppresses the excessive proliferation of smooth muscle cells to reduce in-stent restenosis. However, the efficacy of drug-eluting stents remains limited due to delayed reendothelialization, impaired intimal remodeling ...
Haoshuang Wu, Li Yang, Rifang Luo, Li Li, Tiantian Zheng, Kaiyang Huang, Yumei Qin, Xia Yang, Xingdong Zhang, Yunbing Wang   +9 more
doaj   +1 more source